Related references
Note: Only part of the references are listed.Development of Optimized Tissue-Factor-Targeted Peptide Amphiphile Nanofibers to Slow Noncompressible Torso Hemorrhage
Mia K. Klein et al.
ACS NANO (2020)
Development of Fractalkine-Targeted Nanofibers that Localize to Sites of Arterial Injury
Hussein A. Kassam et al.
NANOMATERIALS (2020)
Peptide Amphiphile Supramolecular Nanostructures as a Targeted Therapy for Atherosclerosis
Neel A. Mansukhani et al.
MACROMOLECULAR BIOSCIENCE (2019)
Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer
Gareth D. Healey et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
Marc Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Targeted Delivery of Sildenafil for Inhibiting Pulmonary Vascular Remodeling
Bingbing Li et al.
HYPERTENSION (2019)
The RAGE signaling pathway is involved in intestinal inflammation and represents a promising therapeutic target for Inflammatory Bowel Diseases
M. Body-Malapel et al.
MUCOSAL IMMUNOLOGY (2019)
Atheroma Niche-Responsive Nanocarriers for Immunotherapeutic Delivery
Erica B. Peters et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Production and application of HMGB1 derived recombinant RAGE-antagonist peptide for anti-inflammatory therapy in acute lung injury
Seonyeong Lee et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity
Fang Fang et al.
HUMAN MOLECULAR GENETICS (2018)
Echocardiography allows for analysis of pulmonary arterial flow in mice with congenital diaphragmatic hernia
Mansi Shah et al.
JOURNAL OF SURGICAL RESEARCH (2018)
Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension
Kazufumi Nakamura et al.
PLOS ONE (2018)
Nanoparticle-Mediated Targeting of Pitavastatin to Small Pulmonary Arteries and Leukocytes by Intravenous Administration Attenuates the Progression of Monocrotaline-Induced Established Pulmonary Arterial Hypertension in Rats
Kenzo Ichimura et al.
INTERNATIONAL HEART JOURNAL (2018)
Peptide Amphiphile Nanostructures for Targeting of Atherosclerotic Plaque and Drug Delivery
Miranda M. So et al.
ADVANCED BIOSYSTEMS (2018)
Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis
T. Kwak et al.
ONCOGENE (2017)
Blockade of RAGE ameliorates elastase-induced emphysema development and progression via RAGE-DAMP signaling
Hanbyeol Lee et al.
FASEB JOURNAL (2017)
What's in a side effect? The association between pulmonary vasodilator adverse drug events and clinical outcomes in patients with pulmonary arterial hypertension
Peter J. Leary et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension
Victor Segura-Ibarra et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Programmable Assembly of Peptide Amphiphile via Noncovalent-to-Covalent Bond Conversion
Kohei Sato et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
All the RAGE in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses
Elizabeth A. Oczypok et al.
PAEDIATRIC RESPIRATORY REVIEWS (2017)
Angiotensin I-converting enzyme inhibitory peptides from Sipuncula (Phascolosoma esculenta): Purification, identification, molecular docking and antihypertensive effects on spontaneously hypertensive rats
Mingrong Guo et al.
PROCESS BIOCHEMISTRY (2017)
Cellular uptake of nanoparticles: journey inside the cell
Shahed Behzadi et al.
CHEMICAL SOCIETY REVIEWS (2017)
RAGE-mediated extracellular matrix proteins accumulation exacerbates HySu-induced pulmonary hypertension
Daile Jia et al.
CARDIOVASCULAR RESEARCH (2017)
Tissue-Factor Targeted Peptide Amphiphile Nanofibers as an Injectable Therapy To Control Hemorrhage
Courtney E. Morgan et al.
ACS NANO (2016)
Water-Floating Giant Nanosheets from Helical Peptide Pentamers
Jaehun Lee et al.
ACS NANO (2016)
Targeted Nitric Oxide Delivery by Supramolecular Nanofibers for the Prevention of Restenosis After Arterial Injury
Edward S. M. Bahnson et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Effects of RAGE-Specific Inhibitor FPS-ZM1 on Amyloid-β Metabolism and AGEs-Induced Inflammation and Oxidative Stress in Rat Hippocampus
Yan Hong et al.
NEUROCHEMICAL RESEARCH (2016)
Change in the Molecular Dimension of a RAGE-Ligand Complex Triggers RAGE Signaling
Jing Xue et al.
STRUCTURE (2016)
Five-Year Outcomes of Patients Enrolled in the REVEAL Registry
Harrison W. Farber et al.
CHEST (2015)
Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension
Jared M. McLendon et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Encapsulation of beraprost sodium in nanoparticles: Analysis of sustained release properties, targeting abilities and pharmacological activities in animal models of pulmonary arterial hypertension
Tomoaki Ishihara et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Elvin Blanco et al.
NATURE BIOTECHNOLOGY (2015)
Shape-Dependent Targeting of Injured Blood Vessels by Peptide Amphiphile Supramolecular Nanostructures
Tyson J. Moyer et al.
SMALL (2015)
Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
Aaron H Burstein et al.
BMC Neurology (2014)
Contribution of receptor for advanced glycation end products to vasculature-protecting effects of exercise training in aged rats
Qi Gu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease
Douglas Galasko et al.
NEUROLOGY (2014)
Local and Systemic RAGE Axis Changes in Pulmonary Hypertension: CTEPH and iPAH
Bernhard Moser et al.
PLOS ONE (2014)
Cell death versus cell survival instructed by supramolecular cohesion of nanostructuresl
Christina J. Newcomb et al.
NATURE COMMUNICATIONS (2014)
Tyrosine-mediated two-dimensional peptide assembly and its role as a bio-inspired catalytic scaffold
Hyung-Seok Jang et al.
NATURE COMMUNICATIONS (2014)
Use of echocardiographic pulmonary acceleration time and estimated vascular resistance for the evaluation of possible pulmonary hypertension
Sven-Olof Granstam et al.
CARDIOVASCULAR ULTRASOUND (2013)
Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension
Vivek Gupta et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Critical Role for the Advanced Glycation End-Products Receptor in Pulmonary Arterial Hypertension Etiology
Jolyane Meloche et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Pharmacologic treatments for pulmonary hypertension: exploring pharmacogenomics
Julio D. Duarte et al.
FUTURE CARDIOLOGY (2013)
Coassembled Cytotoxic and Pegylated Peptide Amphiphiles Form Filamentous Nanostructures with Potent Antitumor Activity in Models of Breast Cancer
Daniel J. Toft et al.
ACS NANO (2012)
S100P-Derived RAGE Antagonistic Peptide Reduces Tumor Growth and Metastasis
Thiruvengadam Arumugam et al.
CLINICAL CANCER RESEARCH (2012)
Isolation and Identification of an Angiotensin-I Converting Enzyme Inhibitory Peptide from Yeast (Saccharomyces cerevisiae)
He Ni et al.
CURRENT ANALYTICAL CHEMISTRY (2012)
Is RAGE still a therapeutic target for Alzheimer's disease?
Richard J. Deane
FUTURE MEDICINAL CHEMISTRY (2012)
The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
Eleonore Froehlich
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity
Stephan T. Stern et al.
PARTICLE AND FIBRE TOXICOLOGY (2012)
Inhibition Mechanism and Model of an Angiotensin I-Converting Enzyme (ACE)-Inhibitory Hexapeptide from Yeast (Saccharomyces cerevisiae)
He Ni et al.
PLOS ONE (2012)
PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease
Marwan N. Sabbagh et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2011)
Binding studies of truncated variants of the Aβ peptide to the V-domain of the RAGE receptor reveal Aβ residues responsible for binding
Emilia Gospodarska et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2011)
Biomolecular studies by circular dichroism
Veronica Isabel Dodero et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2011)
Effects of acute Rho kinase inhibition on chronic hypoxia-induced changes in proximal and distal pulmonary arterial structure and function
Rebecca R. Vanderpool et al.
JOURNAL OF APPLIED PHYSIOLOGY (2011)
Hypoxia Does neither Stimulate Pulmonary Artery Endothelial Cell Proliferation in Mice and Rats with Pulmonary Hypertension and Vascular Remodeling nor in Human Pulmonary Artery Endothelial Cells
Lunyin Yu et al.
JOURNAL OF VASCULAR RESEARCH (2011)
Biocatalytic self-assembly of 2D peptide-based nanostructures
Meghan Hughes et al.
SOFT MATTER (2011)
Advanced Glycation End Product Recognition by the Receptor for AGEs
Jing Xue et al.
STRUCTURE (2011)
RAGE: a single receptor fits multiple ligands
Guenter Fritz
TRENDS IN BIOCHEMICAL SCIENCES (2011)
The C-terminal acidic tail is responsible for the inhibitory effects of HMGB1 on efferocytosis
Sami Banerjee et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Monodisperse cylindrical micelles by crystallization-driven living self-assembly
Joe B. Gilroy et al.
NATURE CHEMISTRY (2010)
A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension
Kamal K. Mubarak
RESPIRATORY MEDICINE (2010)
Structural Basis for Ligand Recognition and Activation of RAGE
Michael Koch et al.
STRUCTURE (2010)
Self-assembled polypeptide-block-poly(vinylpyrrolidone) as prospective drug-delivery systems
Lei Wang et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2009)
Irena: tool suite for modeling and analysis of small-angle scattering
Jan Ilavsky et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2009)
Mediating Tumor Targeting Efficiency of Nanoparticles Through Design
Steven D. Perrault et al.
NANO LETTERS (2009)
RAGE, vascular tone and vascular disease
David G. S. Farmer et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Site-specific blockade of RAGE-Vd prevents amyloid-β oligomer neurotoxicity
Emmanuel Sturchler et al.
JOURNAL OF NEUROSCIENCE (2008)
Renal clearance of quantum dots
Hak Soo Choi et al.
NATURE BIOTECHNOLOGY (2007)
A meta-analysis of trials of pulmonary hypertension: A clinical condition looking for drugs and research methodology
Alejandro Macchia et al.
AMERICAN HEART JOURNAL (2007)
Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation
B. Moser et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Hypoxia-induced pulmonary vascular remodeling - Cellular and molecular mechanisms
Kurt R. Stenmark et al.
CIRCULATION RESEARCH (2006)
Pulmonary arterial hypertension
Vallerie V. McLaughlin et al.
CIRCULATION (2006)
Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells
N Demling et al.
CELL AND TISSUE RESEARCH (2006)
An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution
XK Sun et al.
BIOMACROMOLECULES (2005)
RAGE and amyloid beta interactions: Atomic force microscopy and molecular modeling
MO Chaney et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Regulation of human melanoma growth and metastasis by AGE-AGE receptor interactions
R Abe et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response
MA Hofmann et al.
GENES AND IMMUNITY (2002)
Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer
H Kuniyasu et al.
JOURNAL OF PATHOLOGY (2002)
Self-assembly and mineralization of peptide-amphiphile nanofibers
JD Hartgerink et al.
SCIENCE (2001)
Share Paper
